Resveratrol treatment of spinal cord injury in rat model

Spinal cord injury (SCI) is catastrophic and can culminate in disability and death. The routine therapy employed in early stages of SCI currently entails surgical procedures combined with high doses of methylprednisolone (MP). MP is highly controversial for the lack of consensus on its true therapeutic effects. Resveratrol (RES) has recently been recognized as a potential and novel therapeutic drug in SCI. Herein, we investigated the effect of RES in a SCI rat‐model and found significant improvement in Basso–Beattie–Bresnahan scores. Results obtained from histological, immunohistochemistry, and ultra‐structural examinations evidenced the tremendous treatment effect of RES. On the basis of our experimental results, we hypothesize that RES could serve as an effective SCI therapeutic with prolong treatment time following injury. Resveratrol (RES) is a Traditional Chinese Medicine. It did improve spinal cord injury (SCI) by inhibiting apoptosis, whiles also instigating axonal regeneration at lesion sites. RES has the potentiality of serving as future SCI therapeutic; however, further investigations regarding its mechanistic action are warranted.